13G Filing: Scopia Capital and Neuroderm Ltd (NDRM)

Page 10 of 11

Page 10 of 11 – SEC Filing

SIGNATURE

After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

September 11, 2017
(Date)
SCOPIA CAPITAL MANAGEMENT LP
By: /s/ Samantha Nasello
Name:  Samantha Nasello
Title:  CCO
Scopia Management, Inc.
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  Vice President
By: /s/ Matthew Sirovich
Name:  Matthew Sirovich
By: /s/ Jeremy Mindich
Name:  Jeremy Mindich

Note.  Schedules filed in paper format shall include a
signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties for whom copies are to
be sent.

Attention.  Intentional misstatements or omissions of
fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Neuroderm Ltd.

Page 10 of 11